Actemra Shortage: What to Do If You Have Issues Accessing This Biologic Because of COVID-19
Tocilizumab (Actemra), which is used to treat rheumatoid and other inflammatory arthritis, is in short supply due to its emergency use authorization (EUA) as a COVID-19 treatment. Here’s what to know about the issue and what to do if you have trouble getting treatment.
Continue reading